Publications
We introduce books, articles and other materials authored or co-authored by, and interviews with, ABE & PARTNERS attorneys.
-
"Patent royalty claim dismissed due to a demurrer, admitting the reach of an arbitration agreement - Defendants' measures and plaintiffs? risk reduction -"
Source : Japan Commercial Arbitration Journal Vol. 5 [2024]- Article
- IP Disputes
- International Disputes
-
"Amgen v Sanofi/Regeneron in Japan: Function, sequence, mechanism"
Source : LSIPR- Article
- IP Disputes
- Life Science and Health Care
-
"Preliminary injunctions in pharmaceutical patent cases in Japan"
Source : LSIPR- Article
- IP Disputes
- Life Science and Health Care
-
"Patent royalty claim dismissed due to a demurrer, admitting the reach of an arbitration agreement"
Source : JCA Journal- Article
- IP Disputes
- International Disputes
-
"Regimen patents in Japan: LCM failures and successes"
Source : LSIPR- Article
- IP Disputes
- Life Science and Health Care
-
"Generic should sue the Minister of Health, Labour and Welfare instead of filing a DJ action, says IP High Court"
Source : Managing Intellectual Property- Article
- IP Disputes
- Life Science and Health Care
-
"Japan: DOE and cross-border infringement of a biologics process patent"
Source : LSIPR- Article
- IP Disputes
- Life Science and Health Care
-
"Comparative analysis of demonstratives in patent litigation"
Source : Managing Intellectual Property- Article
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
- International Disputes
-
"How are IP, competition and healthcare law keeping up with lightning-speed innovation?"
Source : Research Outreach's video abstract- Article
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
- International Disputes
- Antitrust/Competition
-
"Trade secrets in Japan: Oral information disclosure from memory"
Source : WIPR- Article
- IP Disputes
-
"Japan’s Supreme Court gives first ruling on a Criminal Trade Secret Infringement"
Source : WIPR- Article
- IP Disputes
-
"METI’s ‘Good Faith Negotiation Guidelines for Standard Essential Patent Licenses’"
Source : WIPR- Article
- IP Disputes
- IP Transactions
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"The Japan Patent Office’s ‘Guide to Licensing Negotiations Involving Standard Essential Patents’ (second edition)"
Source : WIPR- Article
- IP Disputes
- IP Transactions
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"[GUEST POST] Antitrust defense to patent infringement in Japan: IP High Court overruled Tokyo District Court in toner cartridge recycling case"
Source : FOSS PATENTS- Article
- IP Disputes
- Antitrust/Competition
-
"Antimonopoly Act defence unsuccessful against patent enforcement"
Source : Managing Intellectual Property(SUMMER 2022)- Article
- IP Disputes
- Antitrust/Competition
-
"Why were Toyota, Honda, and GM sued by Intellectual Ventures? Connected cars and patent litigation"
Source : WIPR- Article
- IP Disputes
- IP Transactions
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"Overseas knockdown production and patent infringement"
Source : Managing Intellectual Property(SUMMER 2022)- Article
- IP Disputes
- IT and Telecommunications
- Cross-Border Transactions
-
"Connected Car and Patent Lawsuit- Intellectual Ventures v. Toyota, Honda, GM-"
Source : Corporate Law A2Z (July)- Article
- IP Disputes
- IP Transactions
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"Why the ‘first penguin’ of pay for delay has not come in Japan: anatomy of a Japan paradox"
Source : Life Sciences Intellectual Property Review- Article
- IP Disputes
- Life Science and Health Care
- Antitrust/Competition
-
"Why the 'first penguin' of Pay for Delay has not come in Japan - Anatomy of a Japan Paradox -"
Source : ABA, Antitrust Law Section, Intellectual Property Committee, tidBITS- Article
- IP Disputes
- Life Science and Health Care
- Antitrust/Competition
-
"FRAND declared SEPs and a warning letter"
Source : Managing Intellectual Property (SPRING 2022)- Article
- IP Disputes
- IP Transactions
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"Will authorised biologics deter biosimilars? Utilising JFTC’s expertise in drug pricing"
Source : Life Sciences Intellectual Property Review- Article
- Life Science and Health Care
- Antitrust/Competition
-
"SEPs and the automotive industry in Japan"
Source : WIPR Patents Live- Article
- IP Disputes
- IP Transactions
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"Japan Supreme Court acquits defendant in Coinhive case"
Source : Managing Intellectual Property (SPRING 2022)- Article
- IT and Telecommunications
-
"Directors’ liability for patent infringement pursuant to the Companies Act"
Source : Managing Intellectual Property Magazine (WINTER 2021)- Article
- IP Disputes
- General Corporate
- Restructuring and Insolvency
-
"A new drug pricing system reform proposal in Japan"
Source : Life Sciences Intellectual Property Review (2021’s most-read contributed articles)- Article
- Life Science and Health Care
-
"Will Authorised Biologics deter Biosimilars? - Utilising JFTC's expertise in drug pricing -"
Source : Fair Trade Magazine (August 2021)- Article
- Life Science and Health Care
- Antitrust/Competition
-
"Assessing the licensing environment of SEPs in Japan"
Source : Managing Intellectual Property Magazine (SUMMER 2021)- Article
- IP Disputes
- IP Transactions
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"Clinical trials for original drugs fall under experimental use exception"
Source : LSPN Connect- Article
- IP Disputes
- Life Science and Health Care
-
"The strategic acquisition and utilisation of SEPs: reviewing Japan’s IP Promotion Plan 2021"
Source : Managing Intellectual Property Magazine (SUMMER 2021)- Article
- IP Disputes
- IP Transactions
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"A closer look at Japan’s desirable patent system in the era of COVID-19"
Source : Managing Intellectual Property Magazine (SUMMER 2021)- Article
- IP Transactions
- Life Science and Health Care
- IT and Telecommunications
- Cross-Border Transactions
-
"Reviewing the JPO’s Hantei (Advisory Opinion) for Essentiality Check"
Source : Managing Intellectual Property Magazine (SUMMER 2021)- Article
- IP Disputes
- IP Transactions
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"Damages awarded based on LED-equipped TV for LED patent infringement"
Source : Managing Intellectual Property Magazine (SUMMER 2021)- Article
- IP Disputes
-
"Courts rule on likelihood of confusion in medical device case"
Source : Managing Intellectual Property Magazine (WINTER 2020)- Article
- IP Disputes
- Life Science and Health Care
-
"Antimonopoly Act defence proves successful against patent enforcement"
Source : Managing Intellectual Property Magazine (SPRING 2021)- Article
- IP Disputes
- Antitrust/Competition
-
"Rituximab biosimilar patent infringement lawsuit"
Source : LSPN Connect- Article
- IP Disputes
- Life Science and Health Care
-
"The Broad Institute’s CRISPR-Cas9 patents"
Source : LSPN Connect- Article
- IP Disputes
- Life Science and Health Care
-
"How was Japanese patent litigation reformed?"
Source : Managing Intellectual Property Magazine (WINTER 2020)- Article
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
-
"Why reverse payment is unlikely to arise in Japan?"
Source : Fair Trade magazine (November 2020)- Article
- IP Disputes
- Life Science and Health Care
- Antitrust/Competition
-
"Inventor of anti-PD-L1 antibody patent"
Source : LSPN Connect- Article
- IP Disputes
- Life Science and Health Care
-
"Fair value calculation of SEPs for multi-component products"
Source : Managing Intellectual Property Magazine (WINTER 2020)- Article
- IP Disputes
- IP Transactions
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"Japan implements new IP mediation proceedings"
Source : Managing Intellectual Property Magazine(Online)- Article
- IP Disputes
-
"Antibodies: Should they be defined by function or sequence?"
Source : Managing Intellectual Property Magazine(Online)- Article
- IP Disputes
- Life Science and Health Care
-
"Japan suffers from trade secret infringement"
Source : Managing Intellectual Property Magazine(Spring 2020)- Article
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
-
"Depriving others of their intellectual property"
Source : Managing Intellectual Property Magazine(Online)- Article
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"Battle of judges on unexpected and remarkable effect"
Source : Managing Intellectual Property Magazine (November/December 2019)- Article
- IP Disputes
- Life Science and Health Care
-
"Inspectoin System: Sacred Sword or Rusty Sword?"
Source : Managing Intellectual Property Magazine (Online)- Article
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
-
"JFTC’s attitude towards Reverse Payment"
Source : Managing Intellectual Property Magazine (September/October 2019)- Article
- IP Disputes
- Life Science and Health Care
- Antitrust/Competition
-
"How is evidence collection and trade secret protection managed during litigation?"
Source : Managing Intellectual Property magazine(Japanese Buyer's Guide 2019)- Article
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
-
"Analysing the first generic drug cartel case"
Source : Managing Intellectual Property Magazine(July/August 2019)- Article
- IP Disputes
- Life Science and Health Care
- Antitrust/Competition
